Navigation Links
Imprelis Lawsuit Deadline: Gilman Law LLP Warns Property Owners Who Sustained Imprelis Tree Damage That They Must Act Now, Before July 28th Court Imposed Deadline
Date:6/13/2013

Boston, MA (PRWEB) June 13, 2013

Gilman Law LLP, a leading consumer protection plaintiffs’ law firm, reports that an Imprelis class action lawsuit settlement has been reached in the U.S. District Court, Eastern District of Pennsylvania, on behalf of property owners who sustained damage to trees on their property, allegedly due to DuPont’s Imprelis herbicide. Gilman Law filed a lawsuit on behalf of a property owner on August 1, 2012 (Case No. 2:12-cv-04343-GP, E.D.PA). The Imprelis lawsuit provides compensation for: property owners, lawn care professionals, and golf courses and other self-applicators. Persons and entities who wish to participate in the Imprelis class action must submit a claim form to the Court no later than June 28, 2013.

Gilman Law LLP is warning all property owners affected by Imprelis that they have only a few days left to opt out of the Imprelis settlement if they feel its terms are inadequate and pursue an individual claim to maximize the recovery of compensation to which they are entitled. By opting out, they will maintain their right to file an individual Imprelis claim against DuPont to obtain compensation for their dead and dying trees and to seek full compensation and remediation. Failure to inform the Court, in writing, of their desire to opt out of the Imprelis class action lawsuit by the June 28th deadline or to file the necessary claim form paperwork will bind them to all of the Court’s Orders, and will forever bar them from filing an individual Imprelis tree damage claim, regardless of whether they sustain damage in the future.

Property owners who have not yet filed a claim form in the Imprelis lawsuit settlement, as well as those considering opting out of the class action settlement, are urged to call Gilman Law LLP today for a free legal evaluation of their case. The firm’s Imprelis lawyers are available to review your potential claim and advise you on the best way to proceed. However, property owners must contact Gilman Law LLP immediately and file the appropriate paperwork before the Court imposed June 28th deadline to ensure they preserve their right to compensation. For more information, call Toll Free at 1-877-428-7374.

About Imprelis Lawsuits
Imprelis herbicide was introduced by DuPont in 2010, and marketed as a more environmentally friendly herbicide than other weed killers. However, the U.S. Environmental Protection Agency (EPA) began investigating Imprelis tree damage and death reports in June 2011, after receiving complaints from Maine, Massachusetts, New Hampshire, Connecticut, as well as all states in the United States, except California and New York. In early August 2011, DuPont announced it would issue an Imprelis recall and stop sales of the herbicide. The EPA issued a Stop Sale and Removal Order (SSRO) for Imprelis on August 11, 2011.

(http://epa.gov/compliance/resources/cases/civil/fifra/dupontimprelis.html; EPA, August 11, 2011)

Property owners may be eligible to participate in the Imprelis class action if they suffered damage to trees following application of Imprelis herbicide before February 11, 2013. Gilman Law LLP is providing complimentary lawsuit consultations to property owners who have questions and concerns regarding the Imprelis lawsuit. For more information, please contact Gilman Law LLP before June 28th, by visiting our website to fill out a free, no obligation case evaluation form, or call Toll Free at 1-877-428-7374.

About Gilman Law LLP
Gilman Law LLP, a leading consumer products, pharmaceutical law and defective medical device law firm, has been recognized for delivering successful results to their clients across a broad range of claims stemming from consumer product injury, mass tort, and class action lawsuits. For over 33 years, the Gilman Law LLP team of highly experienced lawyers has earned renown for tireless work on behalf of their clients on many of today’s most challenging and important legal issues.

Contact:
Gilman Law LLP
60 State Street
Suite 700
Boston, MA 02109
1-877-428-7374

Read the full story at http://www.prweb.com/releases/2013/6/prweb10832247.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Imprelis Lawsuit Filed on Behalf of Mansfield, Ohio Property Owner Who Sustained Extensive Damage to Trees, Allegedly Due to Imprelis Herbicide by Wright & Schulte LLC
2. Imprelis Class Action Lawsuit Plaintiffs Could See Settlement Soon, Clients Can Opt-Out If Settlement Is Insufficient, Reports Wright & Sculte LLC
3. Multiple Imprelis Lawsuits Filed by Wright & Schulte Alleging Imprelis Use Resulted in Extensive Tree Damage and Death
4. Class Action Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Who Allege Imprelis Use Caused Extensive Tree Damage and Death, Reports Wright & Schulte
5. Imprelis Lawsuit Representing Multiple Property Owners Alleging Imprelis Seriously Damaged Their Trees and Other Plant Life Filed By Wright & Schulte
6. Imprelis Lawsuit Filed on Behalf of Indiana Country Club, Alleging That Imprelis Use Seriously Damaged the Club’s Landscape and Profits, Reports Wright & Schulte
7. Imprelis Lawsuit Filed by Wright & Schulte LLC on Behalf of Multiple Lawn Care Companies and Property Owners Who Allege Imprelis Use Caused Extensive Tree Damage
8. Imprelis Lawsuit Filed on Behalf of Multiple Property Owners Nationwide Who Allege Imprelis Use Resulted In Extensive Tree Damage and Death, Reports Wright & Schulte
9. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
10. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
11. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... muscle mass and overall body strength, which often leads to a host of ... Journal of the American Geriatrics Society discovered that good overall muscle ...
(Date:2/27/2017)... ... 27, 2017 , ... Much attention has been paid to the problem of ... opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription pain ... overdoses in male populations.(1) , The proportion of women using illicit drugs is also ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... on laser diffraction analysis as a tool to characterize particle size distributions in ... to obtain improved results and novel scientific findings. It describes methods of optimized ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/26/2017)... ... ... The February 13, 2017, assassination of Kim Jong-nam, the half brother of ... deadly use of chemical weapons. Many questions exist about the effect that nerve agents ... lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and one of the ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... -- International Biophysics Corporation, a global medical device manufacturer based in ... revenue growth in 2016 when compared to the previous year ... was fueled by its AffloVest® sales in the ... its global sales of surgical product lines. Said ... our 25 th year in delivering high-quality, innovative medical ...
(Date:2/27/2017)... Calif. , Feb. 27, 2017   Vitasome ... line of nutritional supplements using its groundbreaking new liposome ... 90 percent of potency through digestion per Physician,s ... supplements solve the problem of nutritional waste and are ... degradation during digestive processes Improve bioavailability ...
(Date:2/27/2017)... Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... development company focused on tissue protection, repair and ... GtreeBNT Co., Ltd., received a positive response from ... trial design for RGN-137 to treat epidermolysis bullosa ... that incorporates Thymosin beta 4 ("Tß4") as the ...
Breaking Medicine Technology: